James Aikins

785 total citations
23 papers, 569 citations indexed

About

James Aikins is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, James Aikins has authored 23 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in James Aikins's work include Chemical Synthesis and Analysis (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Synthesis and biological activity (2 papers). James Aikins is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Synthesis and biological activity (2 papers). James Aikins collaborates with scholars based in United States and Canada. James Aikins's co-authors include Larry C. Blaszczak, Mohammad Zia‐Ebrahimi, Michael S. VanNieuwenhze, Scott C. Mauldin, William J. Hornback, Thomas F. Rocereto, James C. Paulson, Kai Krämer, Thomas A. Crowell and Brian E. Winger and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

James Aikins

21 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Aikins United States 13 320 248 89 66 50 23 569
Colin D. Reynolds United Kingdom 17 584 1.8× 247 1.0× 52 0.6× 46 0.7× 46 0.9× 43 1.1k
Kurt W. Saionz United States 12 271 0.8× 332 1.3× 33 0.4× 48 0.7× 33 0.7× 16 565
Tomas Fex Sweden 15 462 1.4× 271 1.1× 37 0.4× 57 0.9× 38 0.8× 32 817
J. Venkatesh Pratap India 13 482 1.5× 140 0.6× 65 0.7× 13 0.2× 36 0.7× 37 811
C. Yu United States 6 484 1.5× 153 0.6× 29 0.3× 62 0.9× 148 3.0× 7 654
Philip M. Leonard United Kingdom 14 350 1.1× 73 0.3× 163 1.8× 28 0.4× 72 1.4× 19 482
Judith A. Singer United States 13 443 1.4× 140 0.6× 100 1.1× 25 0.4× 46 0.9× 26 766
S. Abdel‐Meguid United States 9 444 1.4× 96 0.4× 134 1.5× 9 0.1× 85 1.7× 15 841
Dominique Guianvarc’h France 18 810 2.5× 267 1.1× 65 0.7× 29 0.4× 50 1.0× 49 1.1k
Boya Feng China 18 354 1.1× 609 2.5× 111 1.2× 12 0.2× 17 0.3× 30 1.0k

Countries citing papers authored by James Aikins

Since Specialization
Citations

This map shows the geographic impact of James Aikins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Aikins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Aikins more than expected).

Fields of papers citing papers by James Aikins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Aikins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Aikins. The network helps show where James Aikins may publish in the future.

Co-authorship network of co-authors of James Aikins

This figure shows the co-authorship network connecting the top 25 collaborators of James Aikins. A scholar is included among the top collaborators of James Aikins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Aikins. James Aikins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aikins, James, et al.. (2021). Cannabidiol suppresses 3-dimensional ovarian cancer growth and may enhance potency of classic and epigenetic therapies. Gynecologic Oncology. 162. S102–S103. 1 indexed citations
2.
Aikins, James, et al.. (2021). Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?. Biomolecules. 11(5). 766–766. 20 indexed citations
3.
4.
5.
Check, Jerome H., et al.. (2020). Abstract 696: Palliative benefits of oral mifepristone treatment for metastatic fibroblastic osteosarcoma. Cancer Research. 80(16_Supplement). 696–696.
6.
Aikins, James, et al.. (2010). Effect of incomplete removal of the tert-butoxycarbonyl protecting group during synthesis of a pharmaceutical drug substance on the residual solvent analysis. Journal of Pharmaceutical and Biomedical Analysis. 52(2). 316–319. 3 indexed citations
7.
Liang, Jian, Richard E. Moore, Eric D. Moher, et al.. (2005). Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors. Investigational New Drugs. 23(3). 213–224. 49 indexed citations
8.
9.
Shepherd, Timothy A., James Aikins, David Bleakman, et al.. (2002). Design and Synthesis of a Novel Series of 1,2-Disubstituted Cyclopentanes as Small, Potent Potentiators of 2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic Acid (AMPA) Receptors. Journal of Medicinal Chemistry. 45(10). 2101–2111. 29 indexed citations
10.
VanNieuwenhze, Michael S., Scott C. Mauldin, Mohammad Zia‐Ebrahimi, et al.. (2002). The First Total Synthesis of Lipid II:  The Final Monomeric Intermediate in Bacterial Cell Wall Biosynthesis. Journal of the American Chemical Society. 124(14). 3656–3660. 100 indexed citations
11.
Check, Jerome H., M. L. Check, David Kiefer, & James Aikins. (2001). Ovarian cancer in a woman previously diagnosed with endometriosis and an extremely high serum CA-125 level.. PubMed. 28(2). 83–5. 5 indexed citations
12.
VanNieuwenhze, Michael S., Scott C. Mauldin, Mohammad Zia‐Ebrahimi, James Aikins, & Larry C. Blaszczak. (2001). The Total Synthesis of Lipid I. Journal of the American Chemical Society. 123(29). 6983–6988. 39 indexed citations
13.
Rocereto, Thomas F., et al.. (2000). Phase II Study of Mifepristone (RU486) in Refractory Ovarian Cancer. Gynecologic Oncology. 77(3). 429–432. 58 indexed citations
14.
Misner, Jerry W., Michael A. Staszak, Christopher W. Doecke, et al.. (2000). Enantioselective Syntheses of 1-Carbacephalosporins from Chemoenzymically Derived β-Hydroxy-α-Amino Acids: Applications to the Total Synthesis of Carbacephem Antibiotic Loracarbef. Tetrahedron. 56(31). 5667–5677. 21 indexed citations
15.
Hitchcock, Stephen A., et al.. (1998). The First Total Synthesis of Bacterial Cell Wall Precursor UDP−N-Acetylmuramyl-Pentapeptide (Park Nucleotide). Journal of the American Chemical Society. 120(8). 1916–1917. 40 indexed citations
16.
17.
18.
Howbert, J. Jeffry, Thomas A. Crowell, Richard W. Harper, et al.. (1990). Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships. Journal of Medicinal Chemistry. 33(9). 2393–2407. 115 indexed citations
19.
Aikins, James, et al.. (1988). A novel regioselective t‐butylation as applied to the synthesis of 5‐cyano‐1‐(1,1‐dimethylethyl)‐N‐methyl‐1H‐pyrazole‐4‐carboxamide. Journal of Heterocyclic Chemistry. 25(5). 1293–1294. 4 indexed citations
20.
Adriaenssens, G.J., John L. Bjorkstam, & James Aikins. (1972). NMR and dielectric-relaxation studies of long-range correlation in ferroelectric KH2AsO4. Journal of Magnetic Resonance (1969). 7(1). 99–104. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colin D. Reynolds Breakdown of academic impact, for papers by Kurt W. Saionz Breakdown of academic impact, for papers by Tomas Fex Breakdown of academic impact, for papers by J. Venkatesh Pratap Breakdown of academic impact, for papers by C. Yu Breakdown of academic impact, for papers by Philip M. Leonard Breakdown of academic impact, for papers by Judith A. Singer Breakdown of academic impact, for papers by S. Abdel‐Meguid Breakdown of academic impact, for papers by Dominique Guianvarc’h Breakdown of academic impact, for papers by Boya Feng
Rankless by CCL
2026